Hemangiosarcoma - 25 Studies Found
Recruiting |
: Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by Surgery : Sarcoma : 2009-04-02 : Drug: sorafenib tosylate |
Completed |
: Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery : Sarcoma : 2005-09-20 : Drug: paclitaxel |
Active, not recruiting |
: Bevacizumab in Treating Patients With Angiosarcoma : Sarcoma : 2006-02-06 : Biological: Bevacizumab Bevacizumab 15 mg/kg IV infusion given on day 1 every 21 days = (1 cycle). |
Active, not recruiting |
: A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas : Soft Tissue Sarcoma : 2010-06-08 : Drug: Axitinib Patients will take axitinib tablets 5 mg by mouth twice daily continuously. There may be |
Not yet recruiting |
: Evaluation of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization. :
|
Completed |
: Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma :
|
Completed |
: Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma :
: |
Completed |
: Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma :
: |